BioCentury
ARTICLE | Company News

Management tracks: Abeona, Dermavant, Assembly

April 3, 2018 10:49 PM UTC

Gene therapy play Abeona Therapeutics Inc. (NASDAQ:ABEO) said President and CEO Timothy Miller will transition to president and CSO. He is succeeded as CEO by Carsten Thiel, who was EVP and chief commercial officer at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN).

The Dermavant Sciences dermatology subsidiary of Roivant Sciences GmbH (Basel, Switzerland) hired David Rubenstein as CSO, Richard Peterson as CFO, Ariel Jasie as chief business and strategy officer and Chris Van Tuyl as general counsel. Rubenstein was VP of discovery and preclinical development at the dermatology unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Peterson was CFO of Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA). Jasie was CBO at Codiak BioSciences Inc. (Cambridge, Mass.). Van Tuyl was a partner in the corporate practice group at Sacks Tierney P.A...